Exposure of cancer cells to 5-FU or other antifolate TS inhibitors acutely upregulates TS, probably due to the inhibition of a negative-feedback mechanism in which the TS protein binds its own mRNA and inhibits its translation [7,12,13]. The gene discussed is TYMS; the disease is cancer.